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INTRODUCTION
Thyroid nodules are commonly encountered in clinical 
practice. Due to the excellent resolution provided by high-
frequency ultrasound (US) devices, thyroid nodules as small 
as 2–3 mm can be detected and the prevalence of thyroid 
nodules has increased to 68%, according to a recent study 
(1-3). Considering that approximately 5–15% of detected 
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nodules will eventually be verified as malignant through 
surgery (4, 5), all guidelines recommend US-guided fine-
needle aspiration (US-FNA) to distinguish malignant from 
benign thyroid nodules, and the results substantially affect 
the management of thyroid nodules (1, 4-9). Compared to 
palpation-guided FNA, the routine use of US guidance has 
significantly reduced the rates of nondiagnostic sampling 
and false-negative aspirates due to selective targeting 
of specific nodules, leading to an overall decline in the 
number of unnecessary surgeries performed for benign 
thyroid nodules and a concurrent increase in thyroid cancer 
yield in thyroidectomy specimens (4, 10, 11). 
However, the success of US-FNA strongly depends on the 
experience of the operator and cytopathologist, as well as 
the intrinsic characteristics of the nodule. Therefore, about 
0.4–40.7% of FNA results are insufficient for diagnosis 
and procedure-related complications still occur, albeit 
infrequently (12-25). In addition, performing repeated 
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should be obtained prior to the procedure (8, 31, 32). 
Antithrombotic agents, such as warfarin, heparin, aspirin, or 
clopidogrel bisulfate are frequently prescribed as prophylaxis 
in patients with coronary and cerebral vascular disease and 
in those at risk for thromboembolic phenomena. 
Interruption of antithrombotic agents can minimize the 
risk of procedure-related bleeding, despite the association 
with major cardiovascular adverse events by returning 
to pre-therapy levels of thromboembolic risk (33). If the 
patient is taking warfarin, the referring physician should 
advise the patient to stop taking the medication for 5 days 
before the procedure, and FNA can be performed if the 
international normalized ratio is less than 1.5 to 1.7 (31). 
If the patient needs to remain in the antithrombotic state 
because of a medical condition, such as a heart condition, 
recent arterial stent placement, or vascular surgery (8, 31), 
another option is for the patient to stop the warfarin 2 days 
before the FNA and begin subcutaneous administration of 
enoxaparin every 12 hours (31). Warfarin may be restarted 
the day after the FNA, and the patient should continue 
to receive enoxaparin until the international normalized 
ratio returns to therapeutic levels (2–3 range) (8, 31). For 
the patients taking anti-platelet agents, like aspirin or 
clopidogrel bisulfate, the patient should refrain from taking 
the medications for 3–5 days before and 3 days after US-
FNA, unless the patient needs to take the medication as 
indicated by the patient’s referring physician (1, 8, 31).
A recent study of 593 patients who underwent US-FNA 
on 788 total neck lesions reported that two hematomas 
developed in 144 patients who were on daily antithrombotic 
medications, while four hematomas developed in the other 
449 patients who were never on those types of medications. 
Therefore, incidences of bleeding-related complications were 
not significantly different between the two groups (34). 
This result indicated that discontinuing antithrombotic 
medications might not be crucial for preventing US-FNA 
related bleeding.
Therefore, the decision to stop taking antithrombotic 
agents to prevent bleeding in patients who will undergo US-
FNA should be judged according to individual circumstances. 
Hence, close consultation with the referring physician is 
essential. However, if it is inevitable that US-FNA of thyroid 
nodule will be performed under conditions with bleeding 
tendency, an experienced operator must carefully perform 
US-FNA using smaller needles with a limited number of 
passes after informing the patient about the slightly 
increased risk of bleeding (8, 31). Additionally, under such 
FNAs potentially increases medical costs and the patient’s 
discomfort (26). 
Accordingly, The Korean Society of Thyroid Radiology 
(KSThR) organized a task force comprised of radiologists 
with 10–20 years of experience in US-FNA of thyroid nodules 
to develop a consensus statement for the procedure. To 
retrieve relevant articles on the procedural aspects of 
US-FNA, a PubMed search was conducted through 2014 
using the following search terms: thyroid nodule, thyroid 
malignancy, US, and fine-needle aspiration (FNA) biopsy. 
Based on the subsequent literature review and expert 
consensus of KSThR, this document will cover the technical 
aspects and pre-/post management of US-FNA of the thyroid 
nodule in detail, as well as the factors influencing cytologic 
adequacy.
Pre-Procedural Evalations: Informed Consent 
and Guidance for Patients with Bleeding 
Tendency 
To provide optimal care for patients with thyroid nodules, 
interdisciplinary collaboration is essential among the 
health care specialists involved in US-based management of 
thyroid nodules, including the radiologist, cytopathologist, 
endocrinologist and surgeon. In addition, standardized 
reporting systems for US-based thyroid imaging and 
cytologic diagnosis, such as Thyroid Imaging Reporting and 
Data System and Bethesda system, are recommended to 
establish better stratification of cancer risk (6, 27). 
Informed consent should be signed by the patient after 
discussing the purpose and procedure of FNA in detail 
using patient-friendly language so that the patient can 
fully understand the procedure (1, 7, 8). It should be 
emphasized that US-FNA is the most reliable and safest 
diagnostic method for thyroid nodules, however, serious 
FNA-related complications such as large hematoma that 
cause upper airway obstruction have occurred in a few 
patients (25, 28-30). In addition, it is recommended to 
explain to the patient that there is a small risk of collecting 
insufficient sample for diagnostic purposes and to explain 
other non-contributory results including the concepts of 
false-negatives and false-positives (7, 8).
Although a screening test for coagulation is not always 
needed, a thorough medical history to assess hemorrhagic 
risk factors, including disorders affecting the coagulation 
cascade (liver cirrhosis, end-stage renal disease, 
hematologic disease) and antithrombotic medications, 
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circumstances, the medical team must maintain compression 
over the puncture site for a longer period than usual (31).
<Summary> 
– Detailed investigation of bleeding tendency is 
recommended for patients with thyroid nodules prior to US-
FNA, although a screening test for coagulation is not always 
needed.
– If US-FNA is performed for patients with bleeding 
tendency, an experienced operator should gently manipulate 
the needle, followed by a longer period of manual 
compression.
Technical Details of US-FNA of Thyroid Nodule 
Local Anesthesia
Because most US-FNAs are well-tolerated and are not 
associated with significant patient pain or discomfort, 
routine use of local anesthesia has not been recommended 
(7, 9, 31, 32). However, some patients may complain of 
pain or discomfort, which can make the procedure less 
tolerable. Therefore, local anesthesia can be used to 
improve the patient’s compliance (7, 9, 31, 32, 35). To 
alleviate patient’s discomfort, approximately 1–2 mL of 
1–2% lidocaine hydrochloride solution may be injected into 
the subcutaneous tissue over the thyroid capsule using a 
small caliber needle. Alternatively, topical lidocaine cream 
can be used to minimize children’s distress (36). Regarding 
the benefit of local anesthesia during US-FNA, one 
study revealed that single needle puncture without local 
anesthesia did not cause significant pain, when compared 
to procedures with local anesthesia (37). So we recommend 
the use of local anesthetic agents for deep, non-palpable 
thyroid nodules that may require two or more needle 
punctures to obtain the specimen (7, 35, 37). 
<Summary>
– Local anesthesia is not routinely recommended to 
prevent pain during US-FNA, but might be helpful for 
multiple needle punctures.
Aspiration Technique 
Before performing US-FNA, the operator should verify the 
bleeding risk of the patient and previous cytologic results 
from medical records if available. The operator should sit 
in front of the screen of the US equipment, usually on the 
right side of patient for ease of handling. The FNA procedure 
is performed with the patient supine, with a pillow placed 
under the shoulders to facilitate neck extension and 
optimize visualization of the area, using a high-resolution 
7.5–14 MHz linear-array transducer. According to US-based 
recommendations for thyroid nodules proposed by the 
KSThR (38) and the American Thyroid Association (4), the 
operator should preferentially select the thyroid nodule that 
shows at least one of the following malignant US findings: 
a taller-than-wide shape, a spiculated or microlobulated 
margin, marked hypoechogenicity, microcalcification, and/or 
macrocalcification. In contrast, US characteristics consistent 
with benignity include a pure cyst, a predominantly cystic 
or cystic nodule with reverberating artifacts and spongiform 
nodules (38, 39). In addition, color Dopper US can be used 
to reveal any blood vessels in and around the nodule so 
that vascular injury can be avoided during the procedure (1, 
35). 
After the patient’s neck is antiseptically swabbed, FNA 
is subsequently performed with the needle oriented either 
parallel or perpendicular to the US probe (1, 9, 31, 32). 
When the needle tip is placed appropriately within the 
target nodule, tissue samples is collected with 6 to 7 
“to-and fro” needle movements over 5–10 seconds, with 
2–3 mL suction applied (35). Because the microscopic 
hemorrhage induced by negative pressure during FNA can 
hamper accurate cytologic interpretation, a repetitive back 
and forth motion of the needle without applying negative 
pressure, known as “capillary sampling”, was proposed as an 
alternative method for obtaining less blood-contaminated 
specimens (9, 12, 17, 32). However, there have been 
concerns about the effectiveness of capillary sampling with 
regards to cellular adequacy. Some studies demonstrated 
that capillary sampling yields higher quality specimens with 
fewer bloody stains compared with FNA (12, 40), whereas 
others indicated that there was no significant difference 
between the two techniques (41-43). To achieve a better 
diagnostic yield, we recommend the “combined method”: 
initial capillary sampling followed by negative pressure, 
depending on the cellularity of the FNA specimen (37). 
In this method, the operator moves the needle back and 
forth repeatedly without suction for a few seconds and 
sequentially applies a minimal amount of negative pressure 
if insufficient amount of aspirates is obtained.
Biopsy specimens should be obtained from different 
quadrants of the nodule to ensure a representative sample 
(1, 9). When an appropriate amount of material has filled 
the needle hub, the syringe-needle unit is rapidly withdrawn 
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after releasing the suction (1, 9, 35). Releasing the suction 
before needle withdrawal forces the aspirated specimen 
into the needle, but not into the needle tract, which 
could prevent potential complications such as needle tract 
seeding (1, 9, 25).
<Summary>
– An operator selects the thyroid nodule to be aspirated, 
based on the US features of the thyroid nodule.
– To obtain sufficient amount of cells by minimizing 
bloody contamination, an operator begins US-FNA by 
capillary sampling with minimal negative pressure, then 
increases the amount of negative pressure depending on 
the US characteristics of the thyroid nodule.
Needle Size and Number of Needle Passes
To obtain a sufficient amount of specimen, the operator 
routinely uses a 2–10 mL plastic syringe attached to a 
conventional 23–25 gauge needle (1, 7, 9, 31, 32). A 
syringe holder may or may not be used, according to the 
preference of the operator. The number of needle passes, 
ranging from 2 to 3, for each thyroid nodule is determined 
depending on the US characteristics of the thyroid nodule 
and the operator’s preference (32). To improve the cellular 
adequacy of FNA, several methods are recommended. For 
example, a gentler manipulating needle technique involving 
small needle size, capillary technique, and short needle 
dwell time, followed by manual compression would be 
effective for preventing bloody aspirates and procedure-
related hematoma when targeting a hypervascular nodule (1, 
9, 12, 40). For cystic or complex lesions, sampling could be 
done from the solid elements and from suspicious areas of 
complex lesions after drainage of the viscous colloid using 
a large needle (1, 7, 31). In addition, a larger needle and/
or greater negative pressure might be helpful to obtain 
adequate specimens from hard nodules (1, 9, 31).
<Summary>
– The needle size or number of passes used in every 
setting of US-FNA would be determined depending on the 
US characteristics of the thyroid nodule and the operator’s 
preference.
Parallel or Perpendicular Technique
In the parallel technique, the needle advances along 
the long axis of the probe and is visualized from the skin 
puncture to the thyroid nodule, allowing the operator to 
observe needle penetration, location of distal tip, and the 
entire pathway of the needle (31, 32). In the perpendicular 
technique, the nodule is positioned in the mid-portion 
of the screen and the point of needle insertion might be 
central, just over the nodule to be targeted (31, 32). The 
needle advances perpendicular to the probe footprint at 
an angle determined by the nodule’s depth and only the 
tip of the needle is visualized when it enters the nodule. 
Therefore, the needle tip should be continuously monitored 
by US to prevent vascular, tracheal or esophageal injury 
during the entire duration of the FNA. 
According to one study comparing parallel and 
perpendicular techniques with regard to specimen adequacy 
from thyroid nodules, the parallel technique significantly 
decreased the overall nondiagnostic sampling compared to 
the perpendicular technique (44). However the sample size 
of the study was small and the two techniques were applied 
to different lesions.
<Summary>
– The decision to select the parallel or perpendicular 
technique for targeting the nodule is considered mainly the 
operator’s preference.
Processing of FNA Samples for Cytologic Diagnosis 
Cytologic details of samples will vary depending on the 
experience of the technical staff or laboratory facilities 
for handing specimens obtained by US-FNA, thus proper 
methods should be applied during smearing, fixation, and 
staining of samples to improve diagnostic yield (1). For 
conventional smear preparations, the syringe-needle unit 
is disassembled first. The empty syringe is then filled with 
air, reconnected to the needle and the needle content is 
extruded onto glass slides. After that, FNA samples fixed in 
95% ethyl alcohol for Papanicolaou staining can be used 
for immediate cytologic assessment (1, 45). Sometimes, 
excessive pressure between the spreader slide and non-
spreader slide results in crush artifacts which may interfere 
with evaluation of nuclear morphology (1, 4). 
Therefore, liquid-based cytology (LBC), originally 
developed for gynecologic cervical smears, was recently 
introduced for the FNA of thyroid nodules due to its specific 
advantages including clear background, a monolayer cell 
preparation, and more convenient handling of specimens 
(1, 45-47). This method is based on a two-step procedure: 
1) fixation of the aspirated material in an alcohol-based 
solution and 2) automated processing of the material to 
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obtain the representative cells in a thin layer on a single 
slide. Previous studies demonstrated that LBC showed 
either a lower nondiagnostic rate or a similar diagnostic 
rate for atypical/neoplastic lesions compared with the 
previous conventional smear method, despite the rising 
cost (1, 7, 46, 47). However, several changes that occur 
during the cellular processing step of LBC, such as loss of 
cell artitecture, cytomorphologic changes of colloid, and 
decrease of inflammatory cells, were pointed out as the 
drawbacks of LBC. Therefore, a dedicated training program 
would be necessary for cytopathologists to maintain the 
diagnsotic accuracy of US-FNA (1, 47). 
To summarize the advantages of two different cytologic 
preparation methods, cellular specimen processing by 
conventional smear techniques enables rapid, real-time 
assessment of sample adequacy and allows for a more 
accurate evaluation of cell architecture and colloids than 
LBC, whereas LBC enables rapid processing of samples with 
clearer backgrounds than conventional smears and the 
possibility of saving material for additional marker studies. 
<Summary>
– LBC might be a complimentary cytologic processing 
step for thyroid nodules alongside the conventional smear.
Immediate Assessment of Cytologic Adequacy 
The role of immediate cytologic assessment is 
controversial (9). Many previous reports have stated that 
immediate assessment of cytologic adequacy at the time of 
FNA significantly decreased the numbers of nondiagnostic 
results and helped to avoid repeated FNAs (10, 48-51). 
However, others did not find a statistically significant 
difference in cytologic adequacy between FNAs of thyroid 
nodules with and without immediate cytological analysis, 
and stated that immediate cytological analysis considerably 
extended the cost and duration of the procedure (52). It 
may not be necessary for the success of the procedure to 
perform an immediate assessment, especially if a highly-
experienced operator with a relatively low nondiagnostic 
rate performs the US-FNA for the thyroid nodule (51). 
Rather, immediate cytologic assessment can be reserved for 
the less-experienced operator and for repeat FNA of thyroid 
nodules with previous nondiagnostic results if available (50, 
51, 53).
<Summary>
– Immediate assessment of cytologic adequacy might be 
helpful depending on the experience of the operator who 
performs US-FNA for the thyroid nodule. 
Post-Procedural Management
Generally, the risk of FNA-related bleeding diminishes 
with a few minutes of manual compression immediately 
after needle withdrawal (31). Upon completion of the FNA 
procedure, the operator should examine the patient’s neck 
to identify any bleeding-related manifestations, such as 
progressive swelling or ecchymosis. In addition, it would 
be empirically recommended for the patient to manually 
compress the skin puncture site for an additional 20–30 
minute observation period after US-FNA and his or her neck 
should be ultrasonographically re-examined if FNA-related 
complications are suspected. This is especially important in 
patients with bleeding tendencies and these patients should 
be observed for 30–60 minutes to detect any bleeding-
related symptoms (31). Local pain or bruising can be 
minimized by an ice pack. The patient should be discharged 
with instructions to seek medical care if sudden swelling or 
unrelenting pain occurs (31).
<Summary>
– Direct manual compression at the biopsy site is essential 
to reduce the risk of procedure-related complication. 
Management of US-FNA Related Complications 
In regard to complications related with US-FNA, there 
is limited epidemiological data on the incidence and the 
relation to techniques including needle size, number of 
passes or the technique used. However, the possibility and 
severity of complications, including hemorrhage, may be 
increased by a medical history of hemorrhagic risk factors, 
thicker needles, vigorous handling of the needle, or lack of 
operator experience (12, 25). Local pain and ecchymosis 
are the most frequent complications related to US-FNA, 
however, serious events are very rare (4, 5, 8, 25, 34). 
Other complications related to US-FNA are as follows: major 
hematoma, subendothelial hematoma, vasovagal reaction, 
trachea or esophageal injury, and tumor seeding (4, 5, 
25). Most of the complications related to US-FNA can be 
sufficiently managed if the physician is aware and the 
patient is informed (8, 9). 
Local Pain and Ecchymosis
Local pain and slight ecchymosis related to minor 
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hematomas are relatively tolerable; however, if they persist, 
mild painkillers such as Tylenol or temporary application of 
an ice pack on the painful area can control the pain very 
well (9). Aspirin or aspirin substitutes (Motrin, Naprosyn) 
should not be taken within 48 hours after the procedure, 
although there is no direct evidence against them. 
Hemorrhage 
Intrathyroidal- or perithyroidal-hemorrhage after US-FNA 
might be caused by venous extravasation into or around 
the nodules. Clinical manifestations of hemorrhage include 
increased pain, swelling and ecchymosis of the neck, 
dyspnea, dysphonia and dysphagia (9, 25). If hemorrhage 
is suspected, the patient’s neck should be sonographically 
examined to ensure stabilization prior to discharging 
the patient. Small to moderate-sized hematomas can be 
successfully managed in out-patient settings with manual 
compression as well as an ice-pack and they usually resolve 
spontaneously within days. Only a few cases of uncontrolled 
hemorrhage, requiring hospital admission and more active 
intervention, have been reported in the literature (25, 28-
30). A massive hematoma may result in tracheal deviation 
and/or compression and can be fatal if acute upper 
airway obstruction develops rapidly. Proper preventive 
efforts should be considered, especially for patients with 
bleeding tendency, before and during the procedure, and 
prompt intervention including endotracheal intubation 
and tracheostomy or decompression surgery (hematoma 
evacuation, ligation and/or thyroidectomy) should be 
considered upon detection. 
Rarely, subendothelial carotid hematoma manifests as 
acute, persistent pain immediately after US-FNA (54). To 
prevent bleeding around the thyroid glands or a potential 
complication such as pseudoaneurysm, firm pressure should 
be applied after confirming the presence of a hematoma. 
Reduced activity and upper positioning of the head can be 
useful to decrease the spread of hematoma along the vessel 
wall. Usually, the hematoma absorbs spontaneously within a 
week. 
Vasovagal Reaction 
Some patients experience vasovagal reactions, such 
as light-headedness, nausea, sweating, clammy hands 
or seizure-like activity, due to pain or anxiety about the 
procedure, prior to, during, or after the procedure (9). 
Especially, seizure-like activities such as uncontrollable 
jerking movements of the arms or legs can make the 
patients feel very scared. The symptoms usually last for 
2–3 minutes. It is advisable to calm the patient by placing 
them in a supine position with legs slightly elevated and 
cold compression applied to the forehead (8, 9). Vital signs 
should be immediately monitored. 
Tumor Seeding
The incidence of needle track seeding following FNA of 
thyroid carcinomas is exceedingly rare and only a few cases 
have been reported in the literature (25). Although the 
evidence is limited, several factors have been presumed to 
cause needle tract seeding, including larger needle size, 
excessive or vigorous needle manipulation, withdrawing 
the needle without releasing suction, and inherent 
characteristics of the lesion (e.g., tumor size, tumor 
aggressiveness). In all described cases, surgical treatment 
successfully removed the tumor seeding, and there was no 
evidence of recurrence during the follow-up period.
Others 
Inadvertent puncture of the trachea during US-FNA may 
manifest as coughing, loss of vacuum in the syringe and/or 
a small amount of hemoptysis and most episodes are self-
limited (25). Other rare complications are pseudoaneurysm, 
recurrent laryngeal nerve palsy, infection or post-FNA 
thyrotoxicosis (9, 25).
Strategies for Minimizing Nondiagnostic 
Results 
Although US guidance ensures safe and exact targeting, 
the rates of nondiagnostic FNA results were highly 
variable and ranged between 0.4–40.7% (12-24, 39, 55). 
“Nondiagnostic” means that the slide prepared by US-
FNA contains fewer than six follicular groups, each of 
which contains 10 or more well-preserved epithelial cells, 
inevitably limiting definitive cytologic interpretation (1, 
5, 6). “Insufficient”, “unsatisfactory”, or “inadequate” can 
also be used in the same sense (5).
Considering the fact that the results of US-FNA have 
primarily supported the decision on whether to manage the 
thyroid nodule medically or surgically, its overall diagnostic 
yield, which reflects the operator’s level of proficiency in 
this technique, should be continuously monitored (1, 56). 
Measuring technical proficiency in US-FNA ideally would 
include monitoring the frequency of nondiagnostic material 
leading to missed or delayed diagnoses of cancers. However, 
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this approach is quite difficult because it requires large 
numbers of cases and access to long term reliable follow-
up in all cases, not just those referred to surgery soon after 
FNA. For these reasons, the nondiagnostic rate of each 
operator, documenting the number of nondiagnostic results 
divided by the number of total FNA procedures, may be 
used as a limited indicator for the level of proficiency (56). 
Based on our expert consensus, it is recommended that 
the US-FNA results of individual operators be periodically 
assessed to confirm whether nondiagnostic rates are less 
than 10–15% or not. 
From the thyroid nodules classified as nondiagnostic after 
initial US-FNAs, up to 34% were reported to be persistently 
nondiagnostic at subsequent US-FNAs. Moreover, 2.0–
14.0% were eventually proved to be malignant upon 
obtaining surgical specimen (14, 15, 23, 24, 39). So, 
nondiagnostic FNA results should not be regarded as simply 
benign. To avoid delays in the detection of malignant 
thyroid nodules and unnecessary surgeries, the American 
Thyroid Association, the American Association of Clinical 
Endocrinologists, the Associazione Medici Endocrinologi, and 
the European Thyroid Association recommend a repeat FNA 
under US-guidance if an initial FNA yields nondiagnostic 
results (1, 4, 6, 57). In general, repeat US-FNA is 
recommended after a minimum interval of three months to 
prevent false-positive interpretations caused by reactive or 
reparative changes (1, 4, 6, 57). In contrast, two recent 
studies demonstrated that repeat FNAs within a shorter 
interval did not significantly influence the diagnostic yield 
of thyroid nodules with previously nondiagnostic results (58, 
59). Therefore, a shorter waiting period may be possible in 
some patients if malignancy is highly suggested by clinical 
or US features (57). Alternatively, a core needle biopsy is 
recommended as a complimentary tool to patients for whom 
previous FNA results are nondiagnostic to improve the 
diagnostic yield of US-FNA (60, 61). 
Apart from cytologic preparation and interpretation 
of FNA specimen, the diagnostic yield of US-FNA highly 
depends on both the US appearance of the thyroid 
nodule and the operator’s experience (Table 1) (12-
22). For example, certain US features such as cystic 
dominancy, macrocalcification, size less than 5–10 mm, 
or hypoechogenicity, have been reported to increase the 
likelihood of nondiagnostic sampling despite highly variable 
nondiagnostic rates between studies (13-16, 18-21, 23, 
39, 62-64). Particularly, cystic dominancy and intranodular 
macrocalcification were reported to be independent findings 
that increase the possibility of nondiagnostic results, even 
when experienced operators performed US-FNA (13). 
Although overall diagnostic rate was significantly 
improved in a previous study from 67% to 89% by 
standardization of technique: US guidance, 25-gauge 
needle, four passes and preparation of samples (four total 
smears: two air-dried, two fixed, with LBC and/or cell 
block) (55), the gauge of the needle, the number of passes 
and the need for negative suction should be determined in 
consideration of the US features of the individual thyroid 
nodule. For example, a 22-gauge or larger needle and/or 
greater negative suction pressure would be recommended 
for a hard thyroid nodule from which sufficient amount 
of cells could not be obtained easily, while a smaller 
needle or capillary sampling would be appropriate for 
targeting a hypervascular thyroid nodule (1, 9, 12, 31, 
40). Especially for a nodule with peripheral calcification, it 
would be helpful to target the specific portion that favors 
the possibility of malignancy, such as the area with focal 
discontinuity or soft tissue rim, rather than an egg-shell 
like completely calcified rim (32, 39, 64). Furthermore, 
previous studies indicated that approximately 2.2–2.5% of 
thyroid cancers showed marked cystic changes (> 50%) and 
at least one suspicious feature, such as microcalcification, 
eccentric solid nodule, hypoechogenicity or irregular thick 
wall, coexisted besides the marked cystic changes (62, 63). 
Therefore, FNA sampling should be specifically targeted to 
the internal solid portion that suggests malignancy after 
drainage of cystic content. 
Similar to other operator-dependent procedures, 
significant differences existed in nondiagnostic rates 
when US-FNAs were performed by highly experienced 
versus less experienced groups (13, 14, 19). For example, 
nondiagnostic rates from one comparative study on operator 
experience were 15.6% for radiologists with more than a 
year of experience and 25.8% for those with less (13). In 
a recent study, nondiagnostic US-FNA rate for radiology 
residents progressively declined with training levels. 
Therefore, the researchers emphasized the role of early 
and continued participation in the procedures throughout 
residency (65). To improve the skill of inexperienced 
operators, training should consist of an initial observation 
period to learn the indications and technical aspects of 
US-FNA as well as communication skills (1, 14, 56). Only 
after this observation period should the trainee perform the 
procedure under the supervision of an expert radiologist (14, 
56). 
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<Summary>
– For effective management of thyroid nodules, an 
operator would clearly understand the technical details of 
US-FNA and be responsible for increasing the diagnostic 
yield of FNA by continuous monitoring of his/her 
nondiagnostic rate. 
– Training for US-FNA would include the knowledge of US 
appearances of thyroid nodules, prevention and management 
of procedure-related complications, patient-care skills, as 
well as technical work under the close supervision of an 
expert radiologist.
CONCLUSION
Ultrasound-guided fine needle aspiration has been 
widely used as the main diagnostic method for patients 
with thyroid nodules, which have been increasingly 
detected following advancement of US technique. However, 
the overall diagnostic yield of this method has been 
highly variable. To optimize patient care, safety, and the 
diagnostic yield of US-FNA, radiologists should understand 
the technical details, cytologic preparation, and procedure-
related complications associated with US-FNA.
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